COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-03-16
DOI
10.3389/fimmu.2023.1107438
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Seroconversion after anti‐SARS‐CoV ‐2 mRNA vaccinations among moderate‐to‐severe psoriatic patients receiving systemic biologicals—Prospective observational cohort study
- (2022) Éva Anna Piros et al. Dermatologic Therapy
- Antibody evasion properties of SARS-CoV-2 Omicron sublineages
- (2022) Sho Iketani et al. NATURE
- Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
- (2022) Timothée Bruel et al. NATURE MEDICINE
- Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2
- (2022) Emi Takashita et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
- (2022) Ainsley Ryan Yan Bin Lee et al. BMJ-British Medical Journal
- Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
- (2022) Luuk Wieske et al. Lancet Rheumatology
- Immune response to SARS‐CoV ‐2 mRNA vaccine in psoriasis patients treated with biologics
- (2022) Maruška Marovt et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study
- (2022) David Simon et al. Lancet Rheumatology
- Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics
- (2022) Dario Graceffa et al. Frontiers in Medicine
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
- (2021) David Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease
- (2021) A. Al‐Janabi et al. BRITISH JOURNAL OF DERMATOLOGY
- Psoriasis
- (2021) Christopher E M Griffiths et al. LANCET
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Bimekizumab versus Secukinumab in Plaque Psoriasis
- (2021) Kristian Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- 1558O COVID-19 vaccine in participants (ptcpts) with cancer: Subgroup analysis of efficacy/safety from a global phase III randomized trial of the BNT162b2 (tozinameran) mRNA vaccine
- (2021) S.J. Thomas et al. ANNALS OF ONCOLOGY
- Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases
- (2021) Marcia A Friedman et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
- (2021) Rebecca H Haberman et al. ANNALS OF THE RHEUMATIC DISEASES
- Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma
- (2021) Irit Avivi et al. BRITISH JOURNAL OF HAEMATOLOGY
- German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 1: Treatment goals and treatment recommendations
- (2021) Alexander Nast et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis
- (2021) Laetitia Penso et al. JAMA Dermatology
- The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
- (2021) Satveer K Mahil et al. Lancet Rheumatology
- Common Fundamentals of Psoriasis and Depression
- (2021) Stefanie Hölsken et al. ACTA DERMATO-VENEREOLOGICA
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
- (2021) Satveer K Mahil et al. Lancet Rheumatology
- Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
- (2021) Laura Boekel Lancet Rheumatology
- COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
- (2021) Filippo Fagni et al. Lancet Rheumatology
- Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review
- (2020) Masahiro Kamata et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pneumococcal antibody protection in patients with autoimmune inflammatory rheumatic diseases with varying vaccination status
- (2020) SL Rasmussen et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Efficacy and safety of risankizumab vs. secukinumab in patients with moderate‐to‐severe plaque psoriasis (IMMerge): Results from a phase 3, randomised, open‐label, efficacy assessor‐blinded clinical trial
- (2020) R.B. Warren et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases—a prospective multi-centre cohort study
- (2019) S Bühler et al. RHEUMATOLOGY
- Impfen bei Immundefizienz
- (2019) Norbert Wagner et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences
- (2018) Wolf-Henning Boehncke Frontiers in Immunology
- Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2018) Z.Z.N. Yiu et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety of biologics in psoriasis
- (2017) Masahiro Kamata et al. JOURNAL OF DERMATOLOGY
- Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression
- (2017) J. Koo et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases
- (2016) C. Phan et al. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
- Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy
- (2016) Jennifer deBruyn et al. INFLAMMATORY BOWEL DISEASES
- Association of Psoriasis With the Risk for Type 2 Diabetes Mellitus and Obesity
- (2016) Ann Sophie Lønnberg et al. JAMA Dermatology
- Psoriasis and the Risk of Depression in the US Population
- (2016) Brandon E. Cohen et al. JAMA Dermatology
- Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials
- (2016) Jonathan West et al. PLoS One
- Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry
- (2015) P. Gisondi et al. BRITISH JOURNAL OF DERMATOLOGY
- A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis
- (2015) David Pariser et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients
- (2015) Patrícia Andrade et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Patients with psoriasis are insulin resistant
- (2015) Mette Gyldenløve et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Metabolic Syndrome Prevalence in Psoriasis
- (2014) Aurora Parodi et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences
- (2014) K. Danielsen et al. BRITISH JOURNAL OF DERMATOLOGY
- Feasibility and Significance of Preclinical Diagnosis in Hypertrophic Cardiomyopathy
- (2014) Georgios K Efthimiadis et al. Cardiology in Review
- Psoriasis: to treat or to manage?
- (2014) Ulrich Mrowietz et al. EXPERIMENTAL DERMATOLOGY
- The association of metabolic syndrome and psoriasis: a population- and hospital-based cross-sectional study
- (2014) I.M. Miller et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors
- (2013) Ann G. Coumbe et al. AMERICAN JOURNAL OF MEDICINE
- Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis
- (2013) I.M. Miller et al. BRITISH JOURNAL OF DERMATOLOGY
- Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease
- (2013) Yoshie Hagihara et al. Journal of Crohns & Colitis
- Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors
- (2013) Iben Marie Miller et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study
- (2013) M. Dubreuil et al. RHEUMATOLOGY
- Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies
- (2013) Ehrin J. Armstrong et al. Journal of the American Heart Association
- The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity
- (2011) Wolf-Henning Boehncke et al. EXPERIMENTAL DERMATOLOGY
- Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study*
- (2011) Gionata Fiorino et al. INFLAMMATORY BOWEL DISEASES
- Psoriasis and hypertension: a case-control study
- (2011) S. Armesto et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study
- (2011) S. Adler et al. RHEUMATOLOGY
- Psoriasis and Hypertension: A Case-Control Study
- (2010) AD Cohen et al. ACTA DERMATO-VENEREOLOGICA
- Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.
- (2010) K Abuabara et al. BRITISH JOURNAL OF DERMATOLOGY
- A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease
- (2010) W. Miehsler et al. Journal of Crohns & Colitis
- Psoriasis and the Risk of Diabetes and Hypertension
- (2009) Abrar A. Qureshi et al. ARCHIVES OF DERMATOLOGY
- Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis
- (2008) J.A. Kaye et al. BRITISH JOURNAL OF DERMATOLOGY
- National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents
- (2008) Sean D. Doherty et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis
- (2008) DD Balci et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation